Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Is Eli Lilly's Latest Deal a Gamechanger? - AOL

   www.aol.com/finance/eli-lillys-latest-deal-game...

   At a forward price-to-earnings (P/E) ratio of 56.7, Lilly's stock is a bit pricey compared to the broader market. The forward P/E of the S&P 500 is roughly 20 right now.

3. These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now

   www.aol.com/finance/2-words-explain-why-eli...

   Here's why they make this stock worth a buy. The latest-earnings update has a lot to like Lilly's revenue rose by 26% year over year in the first quarter, reaching more than $8.7 billion.

4. Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep ...

   www.aol.com/finance/eli-lily-ceo-think-bet...

   Eli Lilly CEO Dave Ricks discusses the hot GLP-1 space and how ... Click here for in-depth analysis of the latest health industry news and events impacting stock prices. Show comments. Advertisement.

5. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

6. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

   www.aol.com/news/eli-lilly-lifts-profit-view...

   (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting ...

7. ImClone Systems - Wikipedia

   en.wikipedia.org/wiki/ImClone_Systems

   ImClone's stock price dropped sharply at the end of 2001 when its drug Erbitux, an experimental monoclonal antibody, failed to get the expected Food and Drug Administration (FDA) approval. It was later revealed by the U.S. Securities and Exchange Commission that numerous executives sold their stock before the announcement of the decision after ...